Cargando…
Chemotherapy for biliary tract cancer: real-world experience in a single institute
The standard chemotherapy regimen for unresectable or recurrent biliary tract cancer is gemcitabine combined with cisplatin (GC). To evaluate the effectiveness and safety of chemotherapy in patients with unresectable or recurrent biliary tract cancer in the real world, we retrospectively analyzed th...
Autores principales: | Maeda, Osamu, Ebata, Tomoki, Shimokata, Tomoya, Matsuoka, Ayumu, Inada-Inoue, Megumi, Morita, Sachi, Takano, Yuko, Urakawa, Hiroshi, Miyai, Yuki, Sugishita, Mihoko, Mitsuma, Ayako, Ando, Masahiko, Mizuno, Takashi, Nagino, Masato, Ando, Yuichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nagoya University
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7719462/ https://www.ncbi.nlm.nih.gov/pubmed/33311803 http://dx.doi.org/10.18999/nagjms.82.4.725 |
Ejemplares similares
-
Drug-induced thrombocytopenia associated with trastuzumab in a patient with HER2-positive recurrent gastric cancer
por: Takano, Yuko, et al.
Publicado: (2021) -
Optimal dose of gemcitabine for the treatment of biliary tract or pancreatic cancer in patients with liver dysfunction
por: Shibata, Takashi, et al.
Publicado: (2016) -
EXTRAVASATION OF PEGYLATED-LIPOSOMAL DOXORUBICIN: FAVORABLE OUTCOME AFTER IMMEDIATE SUBCUTANEOUS ADMINISTRATION OF CORTICOSTEROIDS
por: MITSUMA, AYAKO, et al.
Publicado: (2012) -
Correction to: Vitiligo and tumor response in a patient with amelanotic melanoma undergoing nivolumab treatment
por: Furune, Satoshi, et al.
Publicado: (2021) -
Vitiligo and tumor response in a patient with amelanotic melanoma undergoing nivolumab treatment
por: Furune, Satoshi, et al.
Publicado: (2021)